Cover Image
Market Research Report

Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2017

Published by GlobalData Product code 227697
Published Content info 158 Pages
Immediate Delivery Available
Price
Back to Top
Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2017
Published: September 12, 2017 Content info: 158 Pages
Description

GlobalData's Medical Devices sector report, "Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Cataract Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cataract Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cataract Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cataract Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cataract Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0444EPD

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Cataract Surgery Devices Overview 9

3 Products under Development 10

  • 3.1 Cataract Surgery Devices - Pipeline Products by Stage of Development 10
  • 3.2 Cataract Surgery Devices - Pipeline Products by Segment 11
  • 3.3 Cataract Surgery Devices - Pipeline Products by Territory 12
  • 3.4 Cataract Surgery Devices - Pipeline Products by Regulatory Path 13
  • 3.5 Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 14
  • 3.6 Cataract Surgery Devices - Ongoing Clinical Trials 15

4 Cataract Surgery Devices - Pipeline Products under Development by Companies 16

  • 4.1 Cataract Surgery Devices Companies - Pipeline Products by Stage of Development 16
  • 4.2 Cataract Surgery Devices - Pipeline Products by Stage of Development 17

5 Cataract Surgery Devices Companies and Product Overview 19

  • 5.1 Advanced Refractive Technologies Inc Company Overview 19
    • 5.1.1 Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.2 Altacor Ltd Company Overview 21
    • 5.2.1 Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Bausch & Lomb Inc Company Overview 22
    • 5.3.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 Carl Zeiss Meditec AG Company Overview 23
    • 5.4.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.5 Cirle, Inc Company Overview 24
    • 5.5.1 Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.6 Eye Care and Cure Company Overview 25
    • 5.6.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.7 EyeKon Medical Inc Company Overview 26
    • 5.7.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.8 Glaukos Corp Company Overview 62
    • 5.8.1 Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.9 International Biomedical Company Overview 66
    • 5.9.1 International Biomedical Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.10 OptoLight Vision Technology Company Overview 67
    • 5.10.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.11 Paradigm Medical Industries, Inc. (Inactive) Company Overview 70
    • 5.11.1 Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.12 Radiabeam Technologies LLC Company Overview 71
    • 5.12.1 Radiabeam Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.13 Rhexis Biomedical Company Overview 72
    • 5.13.1 Rhexis Biomedical Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.14 Shanghai Haohai Biological Technology Co Ltd Company Overview 73
    • 5.14.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.15 STAAR Surgical Company Company Overview 74
    • 5.15.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.16 Tear Diagno LLC (Inactive) Company Overview 76
    • 5.16.1 Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.17 University of Florida Company Overview 77
    • 5.17.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.18 University of Michigan Company Overview 78
    • 5.18.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.19 University of Texas Medical Branch at Galveston Company Overview 79
    • 5.19.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.20 Valeant Pharmaceuticals International Inc Company Overview 80
    • 5.20.1 Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.21 Wake Forest Baptist Medical Center Company Overview 88
    • 5.21.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 88

6 Cataract Surgery Devices- Recent Developments 89

  • 6.1 Sep 01, 2017: LIGHTMED Appoints Shlomo Alkalay as CEO 89
  • 6.2 Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs 89
  • 6.3 Aug 15, 2017: World's fastest growing IOL Company - Opens Second Manufacturing Facility in Thailand 90
  • 6.4 Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results 91
  • 6.5 Aug 08, 2017: Ocular Therapeutix Reports Second Quarter 2017 Financial Results and Provides Corporate Update 93
  • 6.6 Aug 03, 2017: Ocular Therapeutix Appoints Daniel Bollag, Ph.D., as Senior Vice President, Regulatory Affairs, Pharmacovigilance and Quality 95
  • 6.7 Aug 02, 2017: STAAR Surgical Reports Second Quarter 2017 Results 95
  • 6.8 Aug 02, 2017: Glaukos Announces Second Quarter 2017 Financial Results 96
  • 6.9 Aug 01, 2017: Ocular Therapeutix Announces Antony Mattessich Assumes Role as Chief Executive Officer 97
  • 6.10 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President 98
  • 6.11 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 99
  • 6.12 Jun 26, 2017: Ocular Therapeutix Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 100
  • 6.13 Jun 22, 2017: Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International 100
  • 6.14 Jun 22, 2017: Ocular Therapeutix Announces Executive Transition Plans 101
  • 6.15 Jun 21, 2017: Combining Implantation of Glaukos iStent inject Trabecular Micro-Bypass with Topical Travoprost Provides Sustained IOP Reduction and Favorable Safety Profile, According to New Study 102
  • 6.16 Jun 19, 2017: Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications 103
  • 6.17 Jun 19, 2017: John Paulson Joins Valeant Board Of Directors 103
  • 6.18 May 31, 2017: EMU Health Brings the First Laser Assisted Cataract Removal System to Queens 104
  • 6.19 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 104
  • 6.20 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 105
  • 6.21 May 10, 2017: Santen Reports Fiscal 2016 Consolidated Performance 105
  • 6.22 May 09, 2017: Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range 106
  • 6.23 May 08, 2017: ZEISS Appoints New Fellow 107
  • 6.24 May 08, 2017: At ASCRS 2017, ZEISS showcases SMILE laser vision correction, set to reinvigorate the US refractive surgery market, and SWEPT Source Biometry with the Barrett Suite for reducing the risk of refractive surprises 107
  • 6.25 May 05, 2017: Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership 109
  • 6.26 May 05, 2017: Ocular Therapeutix Reports First Quarter 2017 Financial Results 110
  • 6.27 May 04, 2017: Cirle to Unveil Second-Generation Three-Dimensional Surgical Navigation System at The American Society of Cataract and Refractive Surgery 112
  • 6.28 May 03, 2017: Glaukos Announces First Quarter 2017 Financial Results 113
  • 6.29 May 03, 2017: Anika Reports First Quarter 2017 Financial Results 114
  • 6.30 May 03, 2017: STAAR Surgical Reports First Quarter 2017 Results 114
  • 6.31 Apr 16, 2017: Establishment of Lohmann & Rauscher Tunisie s.a.r.l. 116
  • 6.32 Apr 06, 2017: Bausch + Lomb Receives 510(k) Clearance From FDA For Stellaris Elite Next-Generation Phacoemulsification Platform 116
  • 6.33 Apr 06, 2017: Ocular Therapeutix Appoints George Migausky as Interim Chief Financial Officer 117
  • 6.34 Apr 05, 2017: STAAR Surgical Names Deborah Andrews Interim CFO 117
  • 6.35 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 118
  • 6.36 Mar 15, 2017: Santen Pharmaceutical: Notice of Corporate Officer Appointments 118
  • 6.37 Mar 10, 2017: Ocular Therapeutix Reports Fourth Quarter and Full Year 2016 Financial Results 120
  • 6.38 Mar 06, 2017: First SMILE Vision Correction Procedure for Myopia Performed in the U.S. 122
  • 6.39 Mar 02, 2017: STAAR Surgical Reports Fourth Quarter 2016 Results 123
  • 6.40 Mar 01, 2017: Glaukos Announces Fourth Quarter & Full Year 2016 Financial Results 124
  • 6.41 Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance 125
  • 6.42 Feb 23, 2017: Calhoun Vision Becomes RxSight 129
  • 6.43 Feb 22, 2017: Preeminent Ophthalmologist, L. Jay Katz Joins Glaukos as Chief Medical Officer 129
  • 6.44 Feb 17, 2017: NIDEK launches SZ-1C pre-loaded IOL injection system 130
  • 6.45 Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results 131
  • 6.46 Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011 132
  • 6.47 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 133
  • 6.48 Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016 134
  • 6.49 Feb 06, 2017: Joseph Gilliam to Join Glaukos Corporation as Chief Financial Officer and Senior Vice President of Corporate Development 134
  • 6.50 Feb 01, 2017: Glaukos Promotes Chris M. Calcaterra to Chief Operating Officer 135
  • 6.51 Jan 13, 2017: NIDEK launches the OPD-Scan III VS Refractive Power / Corneal Analyzer 135
  • 6.52 Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors 136
  • 6.53 Dec 19, 2016: Lensar Strategic Restructure In Partnership With Pdl Biopharma 136
  • 6.54 Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology 137
  • 6.55 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend 138
  • 6.56 Nov 17, 2016: Former Valeant Executive And Former Philidor Ceo Charged In Manhattan Federal Court For Illegal Fraud And Kickback Scheme 139
  • 6.57 Nov 10, 2016: Glaukos Announces Third Quarter 2016 Financial Results 141
  • 6.58 Nov 09, 2016: Ocular Therapeutix Reports Third Quarter 2016 Financial Results and Provides Corporate Update 141
  • 6.59 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results 143
  • 6.60 Nov 03, 2016: STAAR Surgical Reports Third Quarter 2016 Results 147
  • 6.61 Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016 148
  • 6.62 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 148
  • 6.63 Oct 13, 2016: Clarity Medical Systems Announces Featured Upgrades to HOLOS IntraOp System at American Academy of Ophthalmology Annual Meeting 149
  • 6.64 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 150
  • 6.65 Oct 12, 2016: Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago 151
  • 6.66 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer 153
  • 6.67 Oct 03, 2016: Santen: Personnel Changes of Corporate Officer 154

7 Appendix 155

  • 7.1 Methodology 155
  • 7.2 About GlobalData 158
  • 7.3 Contact Us 158
  • 7.4 Disclaimer 158

List of Tables

1.1 List of Tables

  • Table 1: Cataract Surgery Devices - Pipeline Products by Stage of Development 10
  • Table 2: Cataract Surgery Devices - Pipeline Products by Segment 11
  • Table 3: Cataract Surgery Devices - Pipeline Products by Territory 12
  • Table 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path 13
  • Table 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 14
  • Table 6: Cataract Surgery Devices - Ongoing Clinical Trials 15
  • Table 7: Cataract Surgery Devices Companies - Pipeline Products by Stage of Development 16
  • Table 8: Cataract Surgery Devices - Pipeline Products by Stage of Development 17
  • Table 9: Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 10: Accupulse Cataract Emulsifier - Product Status 19
  • Table 11: Accupulse Cataract Emulsifier - Product Description 19
  • Table 12: Lens Opacity Threshold System - Product Status 20
  • Table 13: Lens Opacity Threshold System - Product Description 20
  • Table 14: Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 15: SOLO - Product Status 21
  • Table 16: SOLO - Product Description 21
  • Table 17: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 18: Cirle 3-D Surgical Navigation System - Product Status 22
  • Table 19: Cirle 3-D Surgical Navigation System - Product Description 22
  • Table 20: Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 21: VisuMax Femtosecond Laser - Astigmatic Myopia - Product Status 23
  • Table 22: VisuMax Femtosecond Laser - Astigmatic Myopia - Product Description 23
  • Table 23: Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 24: SNS 200 - Product Status 24
  • Table 25: SNS 200 - Product Description 24
  • Table 26: Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 27: Ophthalmic Device - Cataract Surgery - Product Status 25
  • Table 28: Ophthalmic Device - Cataract Surgery - Product Description 25
  • Table 29: EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 30: AcuGel Plus Viscoelastics - Product Status 27
  • Table 31: AcuGel Plus Viscoelastics - Product Description 27
  • Table 32: AcuGel SH Viscoelastics - Product Status 28
  • Table 33: AcuGel SH Viscoelastics - Product Description 28
  • Table 34: AcuGel Viscoelastics - Product Status 28
  • Table 35: AcuGel Viscoelastics - Product Description 29
  • Table 36: Acuity 1 Disposable Injector - Product Status 29
  • Table 37: Acuity 1 Disposable Injector - Product Description 29
  • Table 38: Acuity Capsular Tension Ring 10mm - Product Status 30
  • Table 39: Acuity Capsular Tension Ring 10mm - Product Description 30
  • Table 40: Acuity Capsular Tension Ring 12mm - Product Status 30
  • Table 41: Acuity Capsular Tension Ring 12mm - Product Description 31
  • Table 42: Acurus Capsular Tension Ring 10mm - Product Status 31
  • Table 43: Acurus Capsular Tension Ring 10mm - Product Description 31
  • Table 44: Acurus Capsular Tension Ring 12mm - Product Status 32
  • Table 45: Acurus Capsular Tension Ring 12mm - Product Description 32
  • Table 46: Acurus Gel - Product Status 32
  • Table 47: Acurus Gel - Product Description 33
  • Table 48: Acurus Gel Plus - Product Status 33
  • Table 49: Acurus Gel Plus - Product Description 33
  • Table 50: Acurus SH - Product Status 34
  • Table 51: Acurus SH - Product Description 34
  • Table 52: Acurus-1 Disposable Injector - Product Status 34
  • Table 53: Acurus-1 Disposable Injector - Product Description 35
  • Table 54: Cirrus Biogel Plus - Product Status 35
  • Table 55: Cirrus Biogel Plus - Product Description 35
  • Table 56: Cirrus Biogel SH - Product Status 36
  • Table 57: Cirrus Biogel SH - Product Description 36
  • Table 58: Cirrus Capsular Tension Ring 10mm - Product Status 36
  • Table 59: Cirrus Capsular Tension Ring 10mm - Product Description 37
  • Table 60: Cirrus Capsular Tension Ring 12mm - Product Status 37
  • Table 61: Cirrus Capsular Tension Ring 12mm - Product Description 37
  • Table 62: Cirrus-1 Disposable Injector - Product Status 38
  • Table 63: Cirrus-1 Disposable Injector - Product Description 38
  • Table 64: DGR Capsular Tension Ring 10mm - Product Status 38
  • Table 65: DGR Capsular Tension Ring 10mm - Product Description 39
  • Table 66: DGR Capsular Tension Ring 12mm - Product Status 39
  • Table 67: DGR Capsular Tension Ring 12mm - Product Description 39
  • Table 68: DGR-1 Preloaded-Injector - Product Status 40
  • Table 69: DGR-1 Preloaded-Injector - Product Description 40
  • Table 70: DR Gel - Product Status 40
  • Table 71: DR Gel - Product Description 41
  • Table 72: DR Gel Plus - Product Status 41
  • Table 73: DR Gel Plus - Product Description 41
  • Table 74: DR Gel SH - Product Status 42
  • Table 75: DR Gel SH - Product Description 42
  • Table 76: EyeCoat Plus Viscoelastic - Product Status 42
  • Table 77: EyeCoat Plus Viscoelastic - Product Description 43
  • Table 78: EyeCoat SH Viscoelastic - Product Status 43
  • Table 79: EyeCoat SH Viscoelastic - Product Description 43
  • Table 80: EyeCoat Viscoelastic - Product Status 44
  • Table 81: EyeCoat Viscoelastic - Product Description 44
  • Table 82: Eyekon Capsular Tension Ring 10mm - Product Status 44
  • Table 83: Eyekon Capsular Tension Ring 10mm - Product Description 45
  • Table 84: Eyekon Capsular Tension Ring 12mm - Product Status 45
  • Table 85: Eyekon Capsular Tension Ring 12mm - Product Description 45
  • Table 86: EyeKon-1 Pre-Loaded Injector - Product Status 46
  • Table 87: EyeKon-1 Pre-Loaded Injector - Product Description 46
  • Table 88: Isogel - Product Status 46
  • Table 89: Isogel - Product Description 47
  • Table 90: Isogel Plus - Product Status 47
  • Table 91: Isogel Plus - Product Description 47
  • Table 92: Isogel SH - Product Status 48
  • Table 93: Isogel SH - Product Description 48
  • Table 94: Isotechnics - 1 Preloaded Injector - Product Status 48
  • Table 95: Isotechnics - 1 Preloaded Injector - Product Description 49
  • Table 96: Isotechnics Capsular Tension Ring 10mm - Product Status 49
  • Table 97: Isotechnics Capsular Tension Ring 10mm - Product Description 49
  • Table 98: Isotechnics Capsular Tension Ring 12mm - Product Status 50
  • Table 99: Isotechnics Capsular Tension Ring 12mm - Product Description 50
  • Table 100: MD Gel - Product Status 50
  • Table 101: MD Gel - Product Description 51
  • Table 102: MD Gel Plus - Product Status 51
  • Table 103: MD Gel Plus - Product Description 51
  • Table 104: MD Gel SH - Product Status 52
  • Table 105: MD Gel SH - Product Description 52
  • Table 106: MDR Capsular Tension Ring 10mm - Product Status 52
  • Table 107: MDR Capsular Tension Ring 10mm - Product Description 53
  • Table 108: MDR Capsular Tension Ring 12mm - Product Status 53
  • Table 109: MDR Capsular Tension Ring 12mm - Product Description 53
  • Table 110: MDR-1 Disposable Injector - Product Status 54
  • Table 111: MDR-1 Disposable Injector - Product Description 54
  • Table 112: Suncoast Capsular Tension Ring 10mm - Product Status 54
  • Table 113: Suncoast Capsular Tension Ring 10mm - Product Description 55
  • Table 114: Suncoast Capsular Tension Ring 12mm - Product Status 55
  • Table 115: Suncoast Capsular Tension Ring 12mm - Product Description 55
  • Table 116: Suncoast Gel Viscoelastics - Product Status 56
  • Table 117: Suncoast Gel Viscoelastics - Product Description 56
  • Table 118: Suncoast Plus Viscoelastics - Product Status 56
  • Table 119: Suncoast Plus Viscoelastics - Product Description 57
  • Table 120: Suncoast SH Viscoelastics - Product Status 57
  • Table 121: Suncoast SH Viscoelastics - Product Description 57
  • Table 122: Suncoast-1 Pre-Loaded Injector - Product Status 58
  • Table 123: Suncoast-1 Pre-Loaded Injector - Product Description 58
  • Table 124: EyeKon Medical Inc - Ongoing Clinical Trials Overview 59
  • Table 125: Eyekon Capsular Tension Ring 12mm - EyeKon Medical, Inc. Capsular Tension Ring Clinical Study 60
  • Table 126: Eyekon Capsular Tension Ring 10mm - EyeKon Medical, Inc. Capsular Tension Ring Clinical Study 61
  • Table 127: Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 128: iStent Inject - Cataract Surgery - Product Status 62
  • Table 129: iStent Inject - Cataract Surgery - Product Description 62
  • Table 130: Glaukos Corp - Ongoing Clinical Trials Overview 63
  • Table 131: iStent Inject - Cataract Surgery - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent 64
  • Table 132: iStent Inject - Cataract Surgery - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects with Cataract Treated with Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent 64
  • Table 133: iStent Inject - Cataract Surgery - A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naive to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004% 64
  • Table 134: iStent Inject - Cataract Surgery - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery 65
  • Table 135: iStent Inject - Cataract Surgery - A Randomized Controlled Trial of Cataract Surgery Versus Combined Cataract Surgery with Insertion of iStent Inject 65
  • Table 136: International Biomedical Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 137: ApertureRx Precision Capsulotomy System - Product Status 66
  • Table 138: ApertureRx Precision Capsulotomy System - Product Description 66
  • Table 139: OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 140: Lipshitz Macular Implant - Diabetic Maculopathy - Product Status 67
  • Table 141: Lipshitz Macular Implant - Diabetic Maculopathy - Product Description 67
  • Table 142: OptoLight Vision Technology - Ongoing Clinical Trials Overview 68
  • Table 143: Lipshitz Macular Implant - Diabetic Maculopathy - Efficacy of the Telescopic Mirror Implant for Age-related Macular Degeneration: The MIRROR Trial 69
  • Table 144: Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 145: Photon Laser System - Product Status 70
  • Table 146: Photon Laser System - Product Description 70
  • Table 147: Radiabeam Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 148: Femtosecond UV Laser Pulse Expander - Product Status 71
  • Table 149: Femtosecond UV Laser Pulse Expander - Product Description 71
  • Table 150: Rhexis Biomedical Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 151: Rhexis Biomedical Surgical Instrument - Product Status 72
  • Table 152: Rhexis Biomedical Surgical Instrument - Product Description 72
  • Table 153: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 154: QST Gel - OVD - Product Status 73
  • Table 155: QST Gel - OVD - Product Description 73
  • Table 156: STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 157: Canon-STAAR Preloaded IOL Model KS-3Ai - Product Status 74
  • Table 158: Canon-STAAR Preloaded IOL Model KS-3Ai - Product Description 74
  • Table 159: Preloaded Injector System - Collamer IOL - Product Status 75
  • Table 160: Preloaded Injector System - Collamer IOL - Product Description 75
  • Table 161: Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 162: Cataract Surgical Device - Product Status 76
  • Table 163: Cataract Surgical Device - Product Description 76
  • Table 164: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 165: Tool For Intraocular Lens Removal - Product Status 77
  • Table 166: Tool For Intraocular Lens Removal - Product Description 77
  • Table 167: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 168: Surgical Knife - Product Status 78
  • Table 169: Surgical Knife - Product Description 78
  • Table 170: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 171: Ocular Surgery Device - Product Status 79
  • Table 172: Ocular Surgery Device - Product Description 79
  • Table 173: Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 174: BLS - 001: Cataract - Product Status 80
  • Table 175: BLS - 001: Cataract - Product Description 81
  • Table 176: BLS - 002: Cataract - Product Status 81
  • Table 177: BLS - 002: Cataract - Product Description 81
  • Table 178: BLS - 003: Cataract - Product Status 81
  • Table 179: BLS - 003: Cataract - Product Description 82
  • Table 180: BLS - 004: Cataract - Product Status 82
  • Table 181: BLS - 004: Cataract - Product Description 82
  • Table 182: BLS - 006: Cataract - Product Status 83
  • Table 183: BLS - 006: Cataract - Product Description 83
  • Table 184: BLS - 007: Cataract - Product Status 83
  • Table 185: BLS - 007: Cataract - Product Description 83
  • Table 186: BLS - 008: Cataract - Product Status 84
  • Table 187: BLS - 008: Cataract - Product Description 84
  • Table 188: BLS - 010: Cataract - Product Status 84
  • Table 189: BLS - 010: Cataract - Product Description 84
  • Table 190: BLS - 011: Cataract - Product Status 85
  • Table 191: BLS - 011: Cataract - Product Description 85
  • Table 192: BLS - 015: Cataract - Product Status 85
  • Table 193: BLS - 015: Cataract - Product Description 85
  • Table 194: BLS - 016: Cataract - Product Status 86
  • Table 195: BLS - 016: Cataract - Product Description 86
  • Table 196: Ophthalmic Viscosurgical Device - Product Status 86
  • Table 197: Ophthalmic Viscosurgical Device - Product Description 86
  • Table 198: Stellaris Elite Vision Enhancement System - Product Status 87
  • Table 199: Stellaris Elite Vision Enhancement System - Product Description 87
  • Table 200: Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 201: Aspiration And Irrigation Handpiece Tip - Product Status 88
  • Table 202: Aspiration And Irrigation Handpiece Tip - Product Description 88
  • Table 203: Glossary 157

List of Figures

1.2 List of Figures

  • Figure 1: Cataract Surgery Devices - Pipeline Products by Stage of Development 10
  • Figure 2: Cataract Surgery Devices - Pipeline Products by Segment 11
  • Figure 3: Cataract Surgery Devices - Pipeline Products by Territory 12
  • Figure 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path 13
  • Figure 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 14
  • Figure 6: Cataract Surgery Devices - Ongoing Clinical Trials 15
Back to Top